Symed

Hyderabad, India Founded: 1997 • Age: 29 yrs Acquired By Viyash
APIs are manufactured and drug development services are provided.
Request Access

About Symed

Symed is a company based in Hyderabad (India) founded in 1997 by Parthasaradi Reddy and Mohan Rao Dodda was acquired by Viyash in November 2021.. The company has 949 employees as of April 08, 2024. Symed offers products and services including Active Pharmaceutical Ingredients and Contract Research Services. Symed operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

  • Headquarter Hyderabad, India
  • Employees 949 as on 08 Apr, 2024
  • Founders Parthasaradi Reddy, Mohan Rao Dodda
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Symed Labs Limited
  • Jurisdiction Shaikpet, Telangana, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $63.71 M (USD)
    -0.76
    as on Mar 31, 2020
  • Net Profit
    $9.33 M (USD)
    19.75
    as on Mar 31, 2020
  • EBITDA
    $12.04 M (USD)
    -14.83
    as on Mar 31, 2020
  • Latest Funding Round
  • Investors
  • Employee Count
    949

    as on Apr 08, 2024

  • Acquired by
    Viyash

    (Nov 25, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Symed

Symed offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Contract Research Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Production of high-quality APIs for pharmaceutical applications

Provision of chemistry-related solutions for the industry

People of Symed
Headcount 500-1000
Employee Profiles 4
Employee Profiles
People
Bharath Kumar
Safety Officer
People
Gowtham Reddy .regalla
Assistant General Manager

Unlock access to complete

Funding Insights of Symed

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Symed

Symed has secured backing from 1 investor. Prominent investors backing the company include Viyash. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
APIs and intermediates are manufactured by Viyash as a CDMO.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Symed

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Symed

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Symed Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Symed

Symed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceutical and biotechnology company
domain founded_year HQ Location
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
domain founded_year HQ Location
APIs and drug products are developed and valorized in pharmaceuticals.
domain founded_year HQ Location
APIs, intermediates, and biochemical reagents are developed and manufactured.
domain founded_year HQ Location
APIs are developed and manufactured for therapeutic areas.
domain founded_year HQ Location
Contract development, manufacturing, and analytical services for APIs are offered.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Symed

Frequently Asked Questions about Symed

When was Symed founded?

Symed was founded in 1997.

Where is Symed located?

Symed is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

How many employees does Symed have?

As of Apr 08, 2024, the latest employee count at Symed is 949.

What is the annual revenue of Symed?

Annual revenue of Symed is $63.71M as on Mar 31, 2020.

What does Symed do?

Symed was founded in 1997 in Hyderabad, India, within the pharmaceutical sector. Active pharmaceutical ingredients are produced, alongside drug development services that support formulation and regulatory processes. Operations are centered in India, with a focus on API synthesis and custom development for global clients. Leadership includes co-founders Parthasaradi Reddy and Mohan Rao Dodda, who oversee manufacturing and strategic directions.

Who are the top competitors of Symed?

Symed's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.

What products or services does Symed offer?

Symed offers Active Pharmaceutical Ingredients and Contract Research Services.

Who are Symed's investors?

Symed has 1 investor. Key investors include Viyash.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available